Article

Severe elevation of liver enzymes does not necessarily require treatment interruption in patients treated with a combination of paritaprevir/ritonavir/ombitasvir plus dasabuvir for HCV infection

Journal of Clinical Gastroenterology
DOI: 10.1097/MCG.0000000000000587
0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Saadi, T., & Khoury, J. (2016). Severe elevation of liver enzymes does not necessarily require treatment interruption in patients treated with a combination of paritaprevir/ritonavir/ombitasvir plus dasabuvir for HCV infection. Journal of Clinical Gastroenterology. Lippincott Williams and Wilkins. https://doi.org/10.1097/MCG.0000000000000587

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free